ABSTRACT
Abstract Background: The safety and effectiveness of warfarin depend on anticoagulation control quality. Observational studies associate poor control with increased morbidity, mortality and healthcare costs. Objectives: To develop a profile of non-valvular atrial fibrillation (NVAF) patients treated with warfarin in a Brazilian private ambulatory and hospital setting, evaluate the quality of anticoagulation control, and its association with clinical and economic outcomes. Methods: This retrospective study, through a private health insurance dataset in Brazil, identified NVAF patients treated with warfarin between 01 MAY 2014 to 30 APRIL 2016, described their anticoagulation management, and quantified disease-related costs. Data on demographics, clinical history, concomitant medication and time in therapeutic range (TTR) of international normalized ratio (INR) values were retrieved. Patients were grouped into TTR quartiles, with good control defined as TTR ≥ 65% (Rosendaal method). Major bleeds and all-cause direct medical costs were calculated and compared between good and poor control subgroups. P-values < 0.05 were considered statistically significant. Results: The analysis included 1220 patients (median follow-up: 1.5 years; IQR: 0.5-2.0). On average, each patient received 0.95 monthly INR measurements (mean INR: 2.60 ± 0.88, with 26.1% of values < 2 and 24.8% > 3), (median TTR: 58%; IQR: 47-68%), (mean TTR: 56.6% ± 18.9%). Only 31% of patients were well-controlled (mean TTR: 78% ± 10%), with 1.6% having major bleeds within median follow-up, and direct medical costs per member per year (PMPY) of R$25,352(± R$ 37,762). Poorly controlled patients (69%) were associated with 3.3 times more major bleeds (5.3% vs. 1.6%; p < 0.01) and 40% higher costs (R$35,384 vs. R$25,352; p < 0.01). Conclusions: More than 60% of the patients were below the desired target and the associated costs were higher.
Resumo Fundamento: A segurança e a eficácia da varfarina dependem da qualidade do controle da anticoagulação. Estudos observacionais associam controle deficiente com aumento de morbidade, mortalidade e custos com saúde. Objetivos: Desenvolver um perfil de pacientes com fibrilação atrial não valvar (FANV) tratados com varfarina em ambiente ambulatorial e hospitalar privado brasileiro, avaliar a qualidade do controle da anticoagulação e sua associação com resultados clínicos e econômicos. Métodos: Este estudo retrospectivo, por meio de um conjunto de dados de seguros privados de saúde no Brasil, identificou pacientes com FANV tratados com varfarina entre 01 de maio de 2014 a 30 de abril de 2016, descreveu seu manejo da anticoagulação e quantificou os custos relacionados à doença. Foram recuperados dados demográficos, histórico clínico, medicação concomitante e tempo na faixa terapêutica (TTR) dos valores da razão normalizada internacional (RNI). Os pacientes foram agrupados em quartis de TTR, com um bom controle sendo definido como TTR ≥65% (método de Rosendaal). Sangramentos maiores e custos médicos diretos por todas as causas foram calculados e comparados entre subgrupos de controle bons e ruins. Valores de p < 0,05 foram considerados estatisticamente significantes. Resultados: A análise incluiu 1220 pacientes (mediana de seguimento: 1,5 anos; IIQ: 0,5-2,0). Em média, cada paciente recebeu 0,95 medidas mensais de RNI (RNI média: 2,60 ± 0,88, com 26,1% dos valores < 2 e 24,8% > 3), (mediana de TTR: 58%; IIQ: 47-68%), (TTR médio: 56,6% ± 18,9%). Apenas 31% dos pacientes estavam bem controlados (TTR médio: 78% ± 10%), com 1,6% apresentando grandes sangramentos na mediana do seguimento e custos médicos diretos por membro por ano (PMPY) de R$25.352 (± R$37.762). Pacientes com controle abaixo do ideal (69%) foram associados a 3,3 vezes mais sangramentos graves (5,3% vs. 1,6%; p <0,01) e custos 40% maiores (R$35.384 vs. R$25.352; p < 0,01). Conclusões: Mais de 60% dos pacientes estavam abaixo da meta desejada e os custos associados foram significativamente maiores nesta população.
Subject(s)
Humans , Atrial Fibrillation , Stroke , Warfarin , Brazil , Retrospective Studies , Treatment Outcome , International Normalized Ratio , AnticoagulantsABSTRACT
OBJECTIVES: Quality improvement (QI) initiatives based on data from international registries have been reported previously; however, there is a lack of information on the impact on the costs of medical care associated with the use of these tools. METHODS: Patients admitted due to myocardial infarction (MI), included in the ACTION Registry® and CathPCI Registry®, in a private Brazilian hospital (i.e., the reference hospital) were analyzed. The costs of care of these patients were compared to the costs of MI admissions in nine similar hospitals not included in the same QI program. Regression models were used to analyze the cost change over time between the two groups of hospitals. Readmission rates were compared using logistic regression, adjusting for the same variables as in the cost model. RESULTS: Overall, the annual medical cost inflation in Brazil was higher than the annual cost trend in the reference hospital during the period of analysis. Moreover, the annual in-hospital costs indicate that the reference hospital has a statistically significant 6% lower cost trend for patients with acute MI, compared to patients with the same diagnostic code in the comparison hospitals group, in an adjusted analysis (p-value=0.041). Using multivariable analysis, the readmission rates were also found to be significantly lower in the reference hospital than in the comparison hospitals, with an odds ratio of 0.68 (p-value=0.042). CONCLUSION: The use of the NCDR® as a benchmark to guide QI programs outside the United States was associated with the positive impact of bending the cost curve to below that of national medical inflation and the comparison hospitals' costs, with a lower incidence of hospital readmission.
Subject(s)
Humans , Patient Readmission , Quality Improvement , United States , Brazil , Registries , HospitalsABSTRACT
RESUMO Ao ingressarem no curso de Medicina, os estudantes se sentem eufóricos e realizados. No entanto, os desafios inerentes à formação podem ser fonte de estresse e angústia, comprometendo o bem-estar desses estudantes. Assim, este estudo se propôs a explorar as causas do estresse na formação médica e os modos de enfrentamento dos estudantes de uma universidade em Montreal, Canadá. Trata-se de um estudo exploratório, com abordagem metodológica qualitativa, mediante um questionário semiestruturado. Participaram do estudo 18 estudantes distribuídos entre o primeiro e o quarto ano do curso de Medicina. Os principais eventos estressores mencionados pelos entrevistados foram: dificuldade em conciliar as atividades acadêmicas e a vida pessoal, avaliações de desempenho, relação com professores/residentes e pacientes, além de terem que morar longe da família. Diante desses eventos, os estudantes desenvolveram estratégias adaptativas e algumas não adaptativas. Entre as estratégias adaptativas, eles mencionaram: falar sobre sentimentos negativos, apoio psicológico, atividades de lazer e apoio espiritual. Em relação às respostas não adaptativas, foram observados sentimentos negativos, como angústia e tristeza, negação da realidade, bebida alcoólica e drogas para recreação. Nesse contexto, as universidades precisam reconhecer essa realidade, de modo a construir estratégias institucionais que possam ajudar os estudantes a lidar com os eventos estressores, para que, assistidos nas próprias necessidades, consigam enxergar as necessidades psicossociais dos pacientes.
ABSTRACT When undergraduate students enter medical school they feel euphoric and fulfilled. However, challenges related to academic development may cause feelings of stress and torment, which compromises students’ wellbeing. This study is aimed at exploring the main causes of stress on medical training, and strategies of facing it used by the medical students of the University of Montreal, Canada. This is an exploratory approach, using a qualitative methodology through a semi-structured survey. Eighteen medical students from first to fourth-year were examined. The major stressing events cited by the students were the following: difficulty in reconciling academic work and personal life, performance exams, interaction with teachers and residents, relationship with patients, as well as the fact of living far from their hometown. In order to face these events, medical students develop adaptive and some non-adaptive strategies. Among the adaptive strategies, students mentioned: expressing their negative feelings, psychological support, leisure activities and spiritual support. As far as the non-adaptive answers are concerned, negative feelings were observed, such as distress and sorrow, denial of reality, alcohol use and recreational drug use. In this context, university authorities must review this situation, in such a way as to provide institutional strategies capable of promoting the recognition of their students’ emotional demands. Students could then take better care of the psychosocial aspects of their patients.